Twin Securities’s Verona Pharma VRNA Stock Holding History

Twin Securities’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-501,113	Closed	-$53.5M	–	25
2025 Q3	$53.5M	Buy	+501,113	New	+$52.3M	26.58%	1

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Twin Securities's VRNA Position: Q4 2025 in Review

Twin Securities sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 501,113 shares — an estimated $53.5M sold.

Twin Securities first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $53.5M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Twin Securities reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Twin Securities sold 501,113 Verona Pharma shares in Q4 2025, an estimated $53.5M.
Twin Securities first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Twin Securities's Verona Pharma position peaked at $53.5M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Twin Securities's 13F filing for Q4 2025, filed 17 Feb 2026.